South Korea said Tuesday it will invest 520 billion won ($470 billion) in biotechnology next year as part of efforts to develop treatment and vaccines for COVID-19. The Ministry of Science and ICT said the figure represents a 24.9 percent hike from 2020. The ministry said it will spend 31.7 billion won on COVID-19 treatment and vaccine development next year and 10.2 billion won to acquire technology to respond to ...